Paclitaxel in the multimodality treatment for inflammatory breast carcinoma
โ Scribed by Massimo Cristofanilli; Aman U. Buzdar; Nour Sneige; Terry Smith; Barbara Wasaff; Nuhad Ibrahim; Daniel Booser; Edgardo Rivera; James L. Murray; Vicente Valero; Naoto Ueno; Eva S. Singletary; Kelly Hunt; Eric Strom; Marsha McNeese; Carol Stelling; Gabriel N. Hortobagyi
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 123 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: Although the clinical efficacy of paclitaxel in the treatment of gastric carcinoma has not been clearly defined, recent reports have suggested a possible role in the treatment of upper gastrointestinal carcinomas in vitro and in vivo. in this study, the authors evaluated the efficacy
## Background: A pilot study of a new chemotherapy, the civic regimen, was performed in 58 patients with metastatic breast carcinoma previously treated with chemotherapy with or without hormonal therapy (n = 41). cisplatin, 20 mg/m2/day, was given (days 1-5) every 21 days during a 1-hour intravenou